Replimune Group, Inc. (REPL) vs Y-mAbs Therapeutics, Inc. (YMAB)
Detailed comparison between Replimune Group, Inc., Y-mAbs Therapeutics, Inc..Total Return (%)
Replimune Group, Inc. (REPL)Y-mAbs Therapeutics, Inc. (YMAB)
Which stock do you think will perform better?
Replimune Group, Inc.
REPL
Y-mAbs Therapeutics, Inc.
YMAB
| Metric | Replimune Group, Inc. (REPL) | Y-mAbs Therapeutics, Inc. (YMAB) |
|---|---|---|
| Current Price | $7.96 | $4.05 |
| Change | 0.24 (3.18%) | 0.16 (4.11%) |
| Market Cap | $0.61B | $0.18B |
| Trailing P/E | 0.00 | 0.00 |
| Forward P/E | -2.96 | -6.98 |
| Dividend Yield | 0.00% | 0.00% |
| 52-Week High | $17.00 | $16.11 |
| 52-Week Low | $4.92 | $3.83 |
| Beta | 0.00 | 0.00 |
| Earnings Per Share | $-3.07 | $-0.67 |
Processing data. Please try again later.
Average Return
| Symbol | 1 Month | Year-to-date | 1 Year | 5 Years | 10 Years | Max |
|---|---|---|---|---|---|---|
| REPL | 5.93% | -26.95% | 20.71% | -58.57% | -47.53% | -47.53% |
| YMAB | -17.85% | -37.69% | -66.78% | -89.30% | -83.13% | -83.13% |